DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management

Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Opiate-Related Disorders; Cocaine-Related Disorders

Intervention: Contingency Management (Behavioral); Methadone dose (Drug); Contingency management/Noncontingent incentives (Behavioral); Methadone (Drug)

Phase: Phase 2

Status: Recruiting

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Kenzie Preston, PhD, Principal Investigator, Affiliation: NIDA Intramural Research Program

Overall contact:
Kenzie Preston, PhD, Phone: 410-550-1639, Email: kpreston@intra.nida.nih.gov

Summary

The purpose of this study is to determine if simultaneous abstinence from heroin and cocaine can be elicited by combining two approaches: flexible methadone dosing and voucher-based contingency management in which patients earn incentives for cocaine abstinence.

Clinical Details

Official title: Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Dose Comparison, Parallel Assignment

Primary outcome: abstinence from cocaine and heroin

Secondary outcome:

time to relapse

Psychological and psychosocial outcome

HIV Risk Behaviors

QT interval

urine microalbuminuria

blood lipid profile

Quality of Life

Substance Dependence

methadone plasma and saliva concentration

cortisol and prolactin levels

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- physical dependence on opiates; requiring treatment for cocaine use; able to attend

clinic seven days per week

Exclusion Criteria:

- medical or psychiatric conditions for which methadone is contraindicated; pregnancy;

inability to give informed consent

Locations and Contacts

Kenzie Preston, PhD, Phone: 410-550-1639, Email: kpreston@intra.nida.nih.gov

NIDA Intramural Research Program, Baltimore, Maryland 21224, United States; Recruiting
Kenzie Preston, PhD, Principal Investigator
Additional Information

Starting date: December 2004
Ending date: January 2012
Last updated: June 19, 2008

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009